Home/Bone Biologics/Jeffrey Frelick
JF

Jeffrey Frelick

President, CEO, and Director

Bone Biologics

Therapeutic Areas

Bone Biologics Pipeline

DrugIndicationPhase
NELL-1/DBM Combination ProductSpinal Fusion (Posterolateral Lumbar)Phase 2